Literature DB >> 24985011

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

João Marcus Oliveira Andrade1, Alanna Fernandes Paraíso1, Marcos Vinícius Macedo de Oliveira2, Andréa Maria Eleutério Martins1, João Felício Neto1, André Luiz Sena Guimarães1, Alfredo Maurício de Paula1, Mahboob Qureshi3, Sérgio Henrique Sousa Santos4.   

Abstract

OBJECTIVE: Resveratrol (RSV) is the most studied natural compound that activates sirtuins, which produce beneficial metabolic effects on lipid and glucose metabolism. The aim of the present study was to investigate the role of resveratrol in preventing nonalcoholic fatty liver disease (NAFLD) and expression of liver inflammatory markers in mice treated with a high-fat diet. METHODS AND PROCEDURES: Eighteen male mice were divided into three groups and fed for 60 d with a standard diet (ST), high-fat diet (HFD), or high-fat diet plus resveratrol (HFD + RSV, 30 mg/kg/d). Body weight, food intake, and serum total cholesterol, triacylglycerol, insulin, alanine transaminase (ALT), and aspartate aminotransferase (AST) were evaluated. Liver histology was analyzed. Expression of ACC, PPAR-γ, ChREBP, SREBP-1 c, CPT-1, tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), NF-κB, interleukin 1 β (IL-1 β), and SIRT1 were evaluated by quantitative real-time reverse transcriptase PCR (qRT-PCR).
RESULTS: The major finding of the present study was that RSV reduced body fat, total cholesterol, triacylglycerol, transaminases, and insulin plasma level. These results were accompanied with a significant reduction in TNF-α, IL-6, and NF-κB mRNA expression in the liver. Analyses of liver adipogenesis related genes indicated that ACC, PPAR-γ, and SREBP-1 mRNA expression were significantly suppressed in HFD + RSV mice. In addition, we observed increased expression of SIRT1 in the HFD + RSV group.
CONCLUSIONS: We observed that treatment with resveratrol improved lipid metabolism, and decreased NAFLD and pro-inflammatory profile in liver of mice with obesity-inducible diets. These data suggest an important clinical application of RSV in preventing liver diseases.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Nonalcoholic fatty liver disease; Obesity; Resveratrol; SIRT1

Mesh:

Substances:

Year:  2013        PMID: 24985011     DOI: 10.1016/j.nut.2013.11.016

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  62 in total

Review 1.  Role of alcohol in the development and progression of hepatocellular carcinoma.

Authors:  Iain H McKillop; Laura W Schrum; Kyle J Thompson
Journal:  Hepat Oncol       Date:  2015-11-30

2.  Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin.

Authors:  Weibin Qian; Xinrui Cai; Xinying Zhang; Yingying Wang; Qiuhai Qian; Junichi Hasegawa
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

Review 3.  Anti-obesity effects of resveratrol: comparison between animal models and humans.

Authors:  Alfredo Fernández-Quintela; Christian Carpéné; Maialen Fernández; Leixuri Aguirre; Iñaki Milton-Laskibar; José Contreras; Maria P Portillo
Journal:  J Physiol Biochem       Date:  2016-12-15       Impact factor: 4.158

4.  Effects of pterostilbene in brown adipose tissue from obese rats.

Authors:  Leixuri Aguirre; Iñaki Milton-Laskibar; Elizabeth Hijona; Luis Bujanda; Agnes M Rimando; María P Portillo
Journal:  J Physiol Biochem       Date:  2017-02-27       Impact factor: 4.158

5.  Acute oral treatment with resveratrol and Lactococcus Lactis Subsp. Lactis decrease body weight and improve liver proinflammatory markers in C57BL/6 mice.

Authors:  Keila Lopes Mendes; Deborah de Farias Lelis; Daniela Fernanda de Freitas; Luiz Henrique da Silveira; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães; Janaína Ribeiro Oliveira; Mariléia Chaves Andrade; Sérgio Avelino Mota Nobre; Sérgio Henrique Sousa Santos
Journal:  Mol Biol Rep       Date:  2021-02-14       Impact factor: 2.316

6.  Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver.

Authors:  Yueli Tian; Jingting Ma; Wudong Wang; Lingjuan Zhang; Jia Xu; Kai Wang; Dongfu Li
Journal:  Mol Cell Biochem       Date:  2016-09-09       Impact factor: 3.396

Review 7.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

8.  Resveratrol supplementation improves lipid and glucose metabolism in high-fat diet-fed blunt snout bream.

Authors:  Dingdong Zhang; Yanan Yan; Hongyan Tian; Guangzhen Jiang; Xiangfei Li; Wenbin Liu
Journal:  Fish Physiol Biochem       Date:  2017-09-10       Impact factor: 2.794

9.  Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats.

Authors:  Sugeedha Jeyapal; Uday Kumar Putcha; Venkata Surekha Mullapudi; Sudip Ghosh; Anil Sakamuri; Suryam Reddy Kona; Sai Santosh Vadakattu; Chandana Madakasira; Ahamed Ibrahim
Journal:  Eur J Nutr       Date:  2017-07-04       Impact factor: 5.614

10.  Ethanol extract of Zhongtian hawthorn lowers serum cholesterol in mice by inhibiting transcription of 3-hydroxy-3-methylglutaryl-CoA reductase via nuclear factor-kappa B signal pathway.

Authors:  Hai-Jie Hu; Xue-Gang Luo; Qing-Qing Dong; Ai Mu; Guo-Long Shi; Qiu-Tong Wang; Xiao-Ying Chen; Hao Zhou; Tong-Cun Zhang; Li-Wen Pan
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.